Connection
Angelo D'Alessandro to CRISPR-Cas Systems
This is a "connection" page, showing publications Angelo D'Alessandro has written about CRISPR-Cas Systems.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.100 |
|
|
|
-
Marchenko N, Nesbitt NM, Alexandrova E, Reisz JA, D'Alessandro A, Suh J, Uryasev S, Pennacchia L, Bahou WF. Biliverdin reductase B as a new target in breast cancer. Breast Cancer Res. 2025 Oct 16; 27(1):179.
Score: 0.051
-
Heidarian Y, Fasteen TD, Mungcal L, Buddika K, Mahmoudzadeh NH, Nemkov T, D'Alessandro A, Tennessen JM. Hypoxia-inducible factor 1a is required to establish the larval glycolytic program in Drosophila melanogaster. Mol Metab. 2025 Mar; 93:102106.
Score: 0.049